In addition, although our results provide some evidence that the concomitant use of blood glutathione and blood sTNFR1 tests may improve the sensitivity of cardiac patient diagnostic, further comparison between blood glutathione and biomarkers of heart failure other than sTNFR1, in particular serum BNP peptides, is needed. This evidence concerns the gene NPPB and heart failure.